News

15/05/2017

The 3 main renal biomarkers (FGF 23, 1,25 vit D, 1-84 PTH) in full automation to support the clinical outcome

WEDNESDAY JUNE 14 - EDUW 36
17.00 - 18.00 - MITROPULOS HALL

27/04/2017

DiaSorin launches the new LIAISON® XL Zika Capture IgM, the first and the only  fully automated test for specific and accurate diagnosis of Zika virus infection,  following  the Emergency Use Authorization (EUA) obtained in the United States over the past few weeks.

11/03/2016

Tuesday, April 12

Toxoplasma gondii, cytomegalovirus and Treponema pallidum infection in pregnancy, what's new?

 

28/01/2015

Tuesday, June 23 - EDUW 25
Testing 1,25 Dihydroxyvitamin D: efficiency, automation, clinical need

Tuesday, June 23 - EDUW 23
How efficient and automated can be Serology and Stool testing?

17/04/2013

20th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine
45th Congress of SIBioC

Download DiaSorin workshops schedule & booth info

17/04/2013

20th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine
45th Congress of SIBioC

Download DiaSorin workshops schedule & booth info

28/01/2013

DiaSorin S.p.A. is pleased to announce the launch of the LIAISON® ALDOSTERONE assay on its LIAISON® analyzers family.

22/10/2012

DiaSorin announces the introduction of an auto-dilution for LIAISON® XL murex HBsAg Quant assay, as a result of the company’s commitment to quality and continuous improvement of its products.

12/10/2012

DiaSorin announces the introduction of the new product in its portfolio, LIAISON® XL murex recHTLV-I/II assay, for the qualitative determination of antibodies to Human T-cell Lymphotropic Virus (HTLV) type I and type II (anti-HTLV-I and anti-HTLV-II) in human serum or plasma samples.

10/04/2012

DiaSorin S.p.A. is pleased to announce the launch on its LIAISON® platforms of the Measles IgM and Mumps IgM assays.
These assays use chemiluminescence immunoassay technology on the LIAISON® analyzer for the qualitative determination of IgM antibodies to measles and mumps viruses in human serum or plasma.

20/06/2011

DiaSorin announces the successful development of two new assays for the semi-quantitative determination of antibodies to measles and mumps viruses on the LIAISON® instrument: LIAISON® Measles IgG and LIAISON® Mumps IgG.

06/06/2011

DiaSorin announces the successful development of 2 new assays for detection of antibodies to Mycoplasma pneumoniae on the LIAISON® instrument: LIAISON®Mycoplasma pneumoniae IgG and LIAISON®Mycoplasma pneumoniae IgM.

14/02/2011

DiaSorin announces the release of the LIAISON® N-TACT® PTH II Assay for the determination of parathyroid hormone levels. The LIAISON® N-TACT® PTH II Assay is a chemiluminescent immunoassay for the quantitative determination of intact PTH in Serum and EDTA-plasma, offering excellent precision, accuracy and sensitivity. 

13/07/2010

DiaSorin releases the only fully automated third generation assay for the determination of parathyroid hormone levels. LIAISON® 1-84 PTH is a chemiluminescent immunoassay for the quantitative determination of 1-84 PTH in serum and EDTA-plasma, without cross-reactivity with the 7-84 PTH fragment.

08/03/2010

DiaSorin S.p.A. has announced the successful development of 2 new assays for detection of antibodies to Parvovirus B19 on the LIAISON® instrument: LIAISON® Biotrin Parvovirus B19 IgG and IgM.

05/03/2010

The LIAISON® Calcitonin II Gen shows improved discrimination at low end when compared to the old assay. In addition, out of a population of 267 apparently healthy subjects, selected by normal levels of fT4, TSH and autoantibodies to Thyroglobulin, 98% of all values are below 10 pg/mL.

Pages